Skip to content

Web-based psychological support program for parental caregivers of children with rare chronic diseases

Web-based psychological support program for parental caregivers of children with rare chronic diseases - WEP-CARE

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
DRKS
Registry ID
DRKS00010979
Enrollment
70
Registered
2016-10-07
Start date
2016-05-23
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety symptoms in parents of children with rare disease

Interventions

Group 1: WEP-CARE is a brief manualized cognitive-behavioral intervention, in form of an internet-based writing therapy. WEP-CARE comprises 12 writing assignments (i.e. treatment sessions), over a per
Representation of a goal
Coping with anxiety
Self-care
Reflection and Integration of the therapy contents and Relapses prevention. The intervention is offered in addition to the usual care and will be delivered by carefully trained and supervised psycholo

Sponsors

Land Baden-Württemberg vertreten durch das Universitätsklinikum Ulm
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The study participants are parental caregivers of a child with rare chronic diseases: Age of the index child 0-25 years; Child with diagnosis of a rare chronic disease or suspicion of the child´s RCD; Caregiver´s clinically relevant psychological stress with elevated anxiety symptoms (raw score = 7 in the GAD-7); Access to the Internet during the study participation; Sufficient knowledge of the German language (caregivers); Informed consent for the study participation

Exclusion criteria

Exclusion criteria: Acute suicidality; Psychotic symptoms

Design outcomes

Primary

MeasureTime frame
Anxiety symptoms, measured by the General Anxiety Disorder Questionnaire (GAD-7; Spitzer, Kroenke, Williams et al, 2006), as an online questionnaire at the end of the intervention or waiting period.

Secondary

MeasureTime frame
Fear of Progression (262 Fear of Progression Questionnaire for Caregivers of Youth with Cystic Fibrosis, FoP-Q/C; Fidika, Mai, Herle & Goldbeck, 2014), at the end of the intervention or waiting period; Depressive symptoms (Depression module of the Patient Health Questionnaire PHQ-9; Leo, Kroenke, Duke et al, 2004), at the end of the intervention or waiting period; Quality of life (Ulmer Quality of Life Inventory for Parents of Chronically Ill Children, ULQIE; Goldbeck & Storck, 2000), at the end of the intervention or waiting period; Coping (Questionnaire on Parental Coping, CHIP-D; McCubbin, McCubbin, Cauble & Goldbeck , 2001), at the end of the intervention or waiting period; Quality of life of the child with RCD (was additionally assessed via three questions targeting emotional and physical well-being and the quality of the relationships of the chronically ill child), at the end of the intervention or waiting period; Utilization of health services (Number of checkups, hospital days), at the end of the intervention or waiting period.

Countries

Germany

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026